Roivant Sciences Ltd. 8-K

What Happened
Roivant Sciences Ltd. announced its financial results for the fourth quarter and fiscal year ended March 31, 2026, in a press release dated May 20, 2026. The company filed a Current Report on Form 8‑K (Item 2.02) to disclose the press release and attached it as Exhibit 99.1 to the filing.

Key Details

• Press release announcing quarterly and fiscal year results dated May 20, 2026.
• Reporting period: fourth quarter and fiscal year ended March 31, 2026.
• The press release is included as Exhibit 99.1 to the Form 8‑K (Item 9.01 lists exhibits).
• Form 8‑K was signed and filed on May 20, 2026 by authorized signatory Keyur Parekh.

Why It Matters
This filing notifies investors that Roivant has released its latest earnings and year‑end results; the detailed financial figures (revenue, profit/loss, cash position, guidance) are contained in the attached press release. Investors should review Exhibit 99.1 for the company’s reported earnings, revenue and any commentary on business performance or outlook to assess near‑term implications for the stock.